Cannlabs Stock Current Asset
| CANL Stock | USD 0.0001 0.00 0.00% |
Cannlabs fundamentals help investors to digest information that contributes to Cannlabs' financial success or failures. It also enables traders to predict the movement of Cannlabs Pink Sheet. The fundamental analysis module provides a way to measure Cannlabs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cannlabs pink sheet.
Cannlabs |
Cannlabs Company Current Asset Analysis
Cannlabs' Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Cannlabs Current Asset | 145 K |
Most of Cannlabs' fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cannlabs is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
In accordance with the recently published financial statements, Cannlabs has a Current Asset of 145 K. This is 99.99% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
| All Next | Launch Module |
Cannlabs Fundamentals
| Return On Asset | -3.62 | |||
| Profit Margin | (0.96) % | |||
| Operating Margin | (2.50) % | |||
| Current Valuation | 14.91 M | |||
| Shares Outstanding | 62.63 M | |||
| Price To Earning | (4.81) X | |||
| Price To Book | 25.41 X | |||
| Price To Sales | 6.91 X | |||
| Revenue | 1.36 M | |||
| Gross Profit | 478.11 K | |||
| EBITDA | (3.99 M) | |||
| Net Income | (1.58 M) | |||
| Cash And Equivalents | 17.59 K | |||
| Current Ratio | 0.09 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (1.26 M) | |||
| Earnings Per Share | (0.03) X | |||
| Number Of Employees | 37 | |||
| Beta | 1.56 | |||
| Market Capitalization | 14.76 M | |||
| Total Asset | 1.32 M | |||
| Retained Earnings | (1.64 M) | |||
| Working Capital | (1.53 M) | |||
| Current Asset | 145 K | |||
| Current Liabilities | 1.68 M | |||
| Z Score | -11.5 | |||
| Net Asset | 1.32 M |
About Cannlabs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cannlabs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cannlabs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cannlabs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Cannlabs Pink Sheet
Cannlabs financial ratios help investors to determine whether Cannlabs Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cannlabs with respect to the benefits of owning Cannlabs security.